The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Fenbendazole 222 MG
Fenbendazole 222 MG · FENBENDAZOLE 299.35 mg/mol · Capsule · Oral · B & L Healthcare Products INC
NDC 85130-0100-01 · 120 CAPSULE in 1 BOTTLE, PLASTIC / 222 mol in 1 CAPSULE · UNAPPROVED DRUG OTHER · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Fenbendazole 222 MG (Capsule)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| B & L Healthcare Products INC | FENBENDAZOLE 299.35 mg/mol | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Fenbendazole 222 MG — NDC 85130-0100-01," retrieved September 3, 2026, https://drugdashboards.com/drug/85130010001.
Free to cite with attribution — see how the data is put together.